US Patent Issued to FONDAZIONE CENTRO SAN RAFFAELE on April 29 for "Combined treatment of primary central nervous system lymphoma" (Italian Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,465, issued on April 29, was assigned to FONDAZIONE CENTRO SAN RAFFAELE (Milan).

"Combined treatment of primary central nervous system lymphoma" was invented by Angelo Corti (Milan) and Andres Jose Maria Ferreri (Milan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to the combination of an R-CHOP therapy with an administration of NGR-hTNF or an analog thereof for the treatment of primary central nervous system lymphoma, preferably relapsed/refractory primary central nervous system lymphoma."

The patent was filed on Dec. 2, 2019, under Application No. 17/297,794.

*For further information, including images, charts and tab...